PATENT CLAIM ANALYSIS

Application Number: 16206448
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Claim (Index 2):
The isolated peptide of  claim 1 , comprising the amino acid sequence (SEQ ID NO: 2) TLWTG(V/P)(N/K)P(E/R)ANC(Q/I)(M/I)(M/E)(Y/A/N/D)   (S/G)(S/K)(E/Q)(S/N)(N/P)D(C/S)KL(I/T)L(I/T)LVK   (T/N)G(A/G) (L/I)V(T/N)(A/G)(F/Y)V(Y/T)(V/L)(I/M)G   (V/A)S(N/D)(N/D/Y)(F/V)N(M/T)L(T/F)(T/K)(Y/H/N)   (R/K)N(I/V)(N/S)(F/I)(T/N)(A/V)EL(F/Y)FD(S/A)(A/T)   G(N/H)(L/I)L(T/P)(S/R/D)(L/S)SSLKT(P/D)L(N/E)  X2   X3 (S/Y)(G/K)Q(N/T)A(I/L/D)  X4 \u2003(N/S)A(K/R)(S/G)FMPST   TAYPF  X5 (\u2014/L)(N/P)(N/DN)(N/A)(S/G)(R/T)   (E/H)(N/K/\u2014)  X6 \u2003N  X7 \u2003I(Y/F)G(T/Q)C(H/Y)Y  X8 \u2003ASD   (H/G/R)(T/A)(A/L)FP(I/L)(D/E)(I/V)(S/T)VMLN(Q/R/K)   R(A/L)(I/L/P)(R/N/D)(A/D/N/S)(D/E/R)TSY(C/V)(I/M)   (R/T)(I/V/F)(T/L)WS(W/L)  X9 \u2003(T/A)G(D/L/V)APET(S/T)   (A/Q)(T/A)TL(V/I)TSPFTF(Y/S)YIREDD.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15593578', '14429803', '13158246', '14066353', '15538975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7907650506717383
- 35 USC 102 Novelty (BERT): 0.6404324320524343
- Combined Prediction Score: 0.775731788809808
- Mean Citation Score: 620.776718
- Max Citation Score: 795.7945599999997
- Similarity Product: 539.4023120313261

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test